WHAT TOPICS WERE COVERED?

During the previous Global Liver Health Forums, HCPs have heard 17 leading international experts and discovered the latest updates in NAFLD research and current clinical practice. All sessions were live streamed with interactive Q&A!

  • NAFLD epidemiology and co-morbidities
  • Disease burden and therapeutic approach
  • The value of RWD (real world data)
    MANPOWER studies
  • The NAFLD patient journey
  • Hepatoprotective treatment options
    Including the role of Essential Phospholipids (EPL)
  • NAFLD to MAFLD
    The importance of steatosis in the paradigm shift
  • Detecting steatosis in clinical practice
    EPOCH Registry
  • Essential phospholipids
    Latest Real World data
  • Digital trends in healthcare
    Impact on NAFLD management
  • NAFLD profiling through physician practice
    Polish RESTORE study
  • NAFLD/MAFLD guidelines overview

REPLAY EARLIER WEBINARS

Our previous webinars are free to access. Replay them at your convenience to gain more flexibility, deepen your understanding, and foster professional development.

GLOBAL LIVER HEALTH FORUM 2020

    Insights into NAFLD burden and epidemiology. What does the data tell us? Global insights

    Prof. Zobair M. Younossi

     

    NAFLD and metabolic comorbidities. Current understanding and perspectives

    Prof. Jörn M. Schattenberg

    Therapeutic approaches for NAFLD

    Prof. Marek Hartleb

    Importance of RWE in understanding the current disease landscape: MANPOWER results put into perspective

    Prof. Chavdar Pavlov

    What does a NAFLD patient journey look like? Importance of HR-QoL

    Prof. Huiying Rao

    Emerging role of hepatoprotective treatment options

    Prof. Jian-Gao Fan

    Essential phospholipids. Mechanism of action in liver disease explained

    Prof. Boguslaw Okopien

    The role of the essential phospholipids in NAFLD continuum

    Dr Asad Izziddin Dajani

GLOBAL LIVER HEALTH FORUM 2021

GLOBAL LIVER HEALTH FORUM 2022

    Membrane protection against NAFLD & NASH

    Prof An

    Overview the progress of NASH treatment

    Prof Lu

    Cardiovascular and metabolic risks of MAFLD - implications for clinical practice

    Prof. Hartleb

    Potential molecular mechanisms of EPL - insights from EASL 2022

    Prof. Fricker

    Drug-induced liver injury (DILI) - the importance of early detection

    Prof. Mao

    Global Liver Institute’s Annual Report

    Donna Cryer

ACCESS ALL DOCUMENTATION FROM PREVIOUS SUMMITS

Check out our Infographics and Event Books for more details

1st Global Liver Health Forum

1st GLHF Event Book

2nd Global Liver Health Forum

2nd GLHF Webinar 1 Event Book

2nd GLHF Webinar 2 Event Book

2nd GLHF Webinar 3 Event Book

3rd GLHF Webinar 1 Event Book

3rd GLHF Webinar 2 Event Book

3rd GLHF Webinar 3 Event Book